Therapeutic carrier based on solanesol and hyaluronate for synergistic tumor treatment.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of biological macromolecules"
DOI: 10.1016/j.ijbiomac.2021.12.194
Abstract: The administration of nanodrugs can lead to metabolism related systemic toxicity due to the use of inert carriers in large quantities. Carrier materials that offer therapeutic effects are therefore a promising means of addressing this… read more here.
Keywords: tumor; hyaluronate; drug; carrier ... See more keywords
Neuroprotective potential of solanesol against tramadol induced zebrafish model of Parkinson’s disease: insights from neurobehavioral, molecular, and neurochemical evidence
Sign Up to like & getrecommendations! Published in 2024 at "Drug and Chemical Toxicology"
DOI: 10.1080/01480545.2024.2355542
Abstract: Abstract Parkinson’s disease (PD) is a prevalent neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and subsequent depletion of dopamine in the striatum. Solanesol, an alcohol that… read more here.
Keywords: solanesol; zebrafish model; induced zebrafish; model ... See more keywords
Synthesis of Molecularly Imprinted Polymer via Emulsion Polymerization for Application in Solanesol Separation
Sign Up to like & getrecommendations! Published in 2020 at "Applied Sciences"
DOI: 10.3390/app10082868
Abstract: Solanesol molecularly imprinted polymers (SSO-MIPs) can specifically recognize solanesol to achieve the purpose of improving the purity of solanesol. The obtained high-purity solanesol can be used in pharmaceuticals, such as anti-cancer and anti-ulcer drugs, etc. read more here.
Keywords: via emulsion; imprinted polymer; solanesol; molecularly imprinted ... See more keywords